This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Bexion Pharmaceuticals Inc.. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Title: Ray Takigiku: Innovator in Cancer Treatment
Introduction
Ray Takigiku is a notable inventor based in Covington, KY (US). He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 2 patents, his work focuses on innovative solutions that aim to improve patient outcomes.
Latest Patents
Takigiku's latest patents include groundbreaking pharmaceutical compositions that utilize saposin C and phosphatidylserine. These compositions are designed to treat various types of cancers, showcasing his commitment to advancing medical science. The details of these patents highlight their potential effectiveness in combating cancer, making them a significant addition to the field.
Career Highlights
Ray Takigiku is currently associated with Bexion Pharmaceuticals Inc., where he continues to develop and refine his innovative ideas. His work at Bexion has positioned him as a key player in the pharmaceutical industry, particularly in the realm of cancer therapies.
Collaborations
Some of his notable coworkers include Ellen K Monson and Xiaochen Wei. Their collaborative efforts contribute to the innovative environment at Bexion Pharmaceuticals Inc., fostering advancements in cancer treatment.
Conclusion
Ray Takigiku's contributions to cancer treatment through his patents and work at Bexion Pharmaceuticals Inc. underscore his role as a significant inventor in the pharmaceutical industry. His dedication to innovation continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile